[{"countryName":"Worldwide","languageLinks":[{"languageName":"English","languageUrl":"/#"}]}]
ROCHE SEQUENCING SOLUTIONS
Roche Sequencing Solutions (RSS) is building on Roche’s legacy of innovation to transform next-generation sequencing and its application. By simplifying workflows and expanding assay menus, we are broadening access to genomic data and lowering barriers to routine use.
Timeline
2017
2016
2015
2014
2000
1990
1980
2017
Roche Launches the AVENIO Product Line
The AVENIO portfolio includes products and reagents that aim to make NGS simple and accessible
2016
Harmony® Prenatal Test Access Increases
The Harmony Prenatal Test receives CE mark, increasing availability worldwide. US insurance coverage passes 200 million lives
KAPA RNA HyperPrep Kit Launches
Our popular KAPA HyperPrep DNA library solution extended with introduction of RNA HyperPrep Kits
HEAT-Seq® Target Enrichment Kit Added
Molecular Inversion Probes (MIPs) plus molecular barcodes make HEAT-Seq kit a unique target enrichment solution
2015
Portfolio Strengthened with Acquisition of Products and Expertise in Library Preparation and Assay Development.
Kapa Biosystems, Experts in Library Preparation, Acquired.
ctDNA Assay Technology Acquired
Roche strengthens oncology translational research pipeline by acquiring CAPP Medical
Large Biobank with Longitudinal Lung and Colorectal Samples Acquired
Roche acquires Signature Diagnostics to advance translational research for next-generation sequencing (NGS) diagnostics
2014
Capabilities Expanded Across the NGS Workflow
Semiconductor-Based Sequencing Platform Acquired
Roche buys Genia Technologies, acquiring semiconductor-based Direct Read sequencing technology
Comprehensive Data Analytics Platform Brought on Board
Bina Technologies, developers of a comprehensive genomics information management and analytics platform, purchased by Roche
Roche Enters the NIPT Market with the Harmony Prenatal Test
Roche acquires Ariosa Diagnostics, providers of the Harmony Prenatal Test, a non-invasive prenatal testing (NIPT) service.
RSS Enhances Cancer Genomics Resources with Multiple Acquisitions
Roche adds oncology translational research capabilities with acquisition of Avansci Bio’s MillisectTM tissue dissection technology.
2000
Roche Enters Genomics Market with Benchtop Sequencer
Roche Acquires 454 Life Sciences and Launches the First Benchtop Sequencer
Roche Launches NimbleGen SeqCap® Target Enrichment Products
Roche acquires NimbleGen and launches SeqCap target enrichment product line
1990
First Complete Human Genome Sequence
The first human genome sequenced to 99.9% accuracy is announced
1980
Dawn of the Genomics Era
The first effort to identify and map the human genome begins
